Krystal Biotech, Inc. (NASDAQ: KRYS) reported Q2 EPS of ($1.25), $0.02 better than the analyst estimate of ($1.27).

For earnings history and earnings-related data on Krystal Biotech, Inc. (KRYS) click here.